Characterization of the effects of anti-aging medicine Fructus lycii on beta-amyloid peptide neurotoxicity - PubMed (original) (raw)
Affiliations
- PMID: 17611646
Characterization of the effects of anti-aging medicine Fructus lycii on beta-amyloid peptide neurotoxicity
Man-Shan Yu et al. Int J Mol Med. 2007 Aug.
Abstract
Alzheimer's disease (AD) is an age-related neurodegenerative disease. There are increasing lines of evidence showing that the molecular signaling pathways in aged cells are altered so that cells are susceptible to injury. We and other laboratories have demonstrated the significant involvement of double-stranded RNA-dependent protein kinase (PKR) in beta-amyloid (A beta) peptide neurotoxicity and in AD. Fructus lycii (the fruit of Lycium barbarum) has long been used in oriental medicine as an anti-aging agent. Our previous studies demonstrated that the aqueous extract isolated from L. barbarum exhibited significant protection on cultured neurons against harmful chemical toxins such as A beta and dithiothreitol. We also showed that the polysaccharide-containing extract (LBP) from L. barbarum exhibited neuroprotective effects in the retina against ocular hypertension in a laser-induced glaucoma animal model. In this study, we aimed to investigate whether LBP can elicit neuroprotection to neurons stressed by A beta peptides. Furthermore, we planned to isolate and identify the neuroprotective agent from LBP using chromatographic methods. Our results showed that pretreatment of LBP effectively protected neurons against A beta-induced apoptosis by reducing the activity of both caspase-3 and -2, but not caspase-8 and -9. A new arabinogalactan-protein (LBP-III) was isolated from LBP and attenuated A beta peptide-activated caspase-3-like activity. LBP-III markedly reduced the phosphorylation of PKR triggered by A beta peptide. Since the phosphorylation state of PKR increased with age, reduction of its phosphorylation triggered by A beta peptide may implicate that LBP-III from Fructus lycii is a potential neuroprotective agent in AD. As herbal medicine has received increasing attention for the treatment of AD, our study will open a window for the development of a neuroprotective agent for anti-aging from Chinese medicine.
Similar articles
- Neuroprotective effects of anti-aging oriental medicine Lycium barbarum against beta-amyloid peptide neurotoxicity.
Yu MS, Leung SK, Lai SW, Che CM, Zee SY, So KF, Yuen WH, Chang RC. Yu MS, et al. Exp Gerontol. 2005 Aug-Sep;40(8-9):716-27. doi: 10.1016/j.exger.2005.06.010. Exp Gerontol. 2005. PMID: 16139464 - Characterizing the neuroprotective effects of alkaline extract of Lycium barbarum on beta-amyloid peptide neurotoxicity.
Ho YS, Yu MS, Lai CS, So KF, Yuen WH, Chang RC. Ho YS, et al. Brain Res. 2007 Jul 16;1158:123-34. doi: 10.1016/j.brainres.2007.04.075. Epub 2007 May 6. Brain Res. 2007. PMID: 17568570 - Evaluation of Samjunghwan, a traditional medicine, for neuroprotection against damage by amyloid-beta in rat cortical neurons.
Kim HG, Ju MS, Park H, Seo Y, Jang YP, Hong J, Oh MS. Kim HG, et al. J Ethnopharmacol. 2010 Aug 9;130(3):625-30. doi: 10.1016/j.jep.2010.05.040. Epub 2010 Jun 9. J Ethnopharmacol. 2010. PMID: 20538052 - Use of anti-aging herbal medicine, Lycium barbarum, against aging-associated diseases. What do we know so far?
Chang RC, So KF. Chang RC, et al. Cell Mol Neurobiol. 2008 Aug;28(5):643-52. doi: 10.1007/s10571-007-9181-x. Epub 2007 Aug 21. Cell Mol Neurobiol. 2008. PMID: 17710531 Review. - [Therapy of Alzheimer disease].
Kovács T. Kovács T. Neuropsychopharmacol Hung. 2009 Mar;11(1):27-33. Neuropsychopharmacol Hung. 2009. PMID: 19731816 Review. Hungarian.
Cited by
- Establishment of a comprehensive list of candidate antiaging medicinal herb used in korean medicine by text mining of the classical korean medical literature, "dongeuibogam," and preliminary evaluation of the antiaging effects of these herbs.
Choi MJ, Choi BT, Shin HK, Shin BC, Han YK, Baek JU. Choi MJ, et al. Evid Based Complement Alternat Med. 2015;2015:873185. doi: 10.1155/2015/873185. Epub 2015 Mar 10. Evid Based Complement Alternat Med. 2015. PMID: 25861371 Free PMC article. - Traditional Chinese Medicine as a Promising Strategy for the Treatment of Alzheimer's Disease Complicated With Osteoporosis.
Xu W, Jiang Y, Wang N, Bai H, Xu S, Xia T, Xin H. Xu W, et al. Front Pharmacol. 2022 Jun 1;13:842101. doi: 10.3389/fphar.2022.842101. eCollection 2022. Front Pharmacol. 2022. PMID: 35721142 Free PMC article. Review. - Effects of Lycium barbarum (goji berry) on dry eye disease in rats.
Chien KJ, Horng CT, Huang YS, Hsieh YH, Wang CJ, Yang JS, Lu CC, Chen FA. Chien KJ, et al. Mol Med Rep. 2018 Jan;17(1):809-818. doi: 10.3892/mmr.2017.7947. Epub 2017 Nov 3. Mol Med Rep. 2018. PMID: 29115477 Free PMC article. - Clinically relevant small-molecule promotes nerve repair and visual function recovery.
Au NPB, Kumar G, Asthana P, Gao F, Kawaguchi R, Chang RCC, So KF, Hu Y, Geschwind DH, Coppola G, Ma CHE. Au NPB, et al. NPJ Regen Med. 2022 Oct 1;7(1):50. doi: 10.1038/s41536-022-00233-8. NPJ Regen Med. 2022. PMID: 36182946 Free PMC article. - Erratum: Modulation of microglia by Wolfberry on the survival of retinal ganglion cells in a rat ocular hypertension model.
Chiu K, Chan HC, Yeung SC, Yuen WH, Zee SY, Chang RC, So KF. Chiu K, et al. J Ocul Biol Dis Infor. 2009 Sep;2(3):127-136. doi: 10.1007/s12177-009-9035-5. Epub 2009 Sep 16. J Ocul Biol Dis Infor. 2009. PMID: 20046845 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous